Prime Editing Unlocks a Universal Strategy for Restoring Lost Proteins
November 22, 2025
Brand Name :
Adderall, Mydayis, Adderall XR
Synonyms :
amphetamine/dextroamphetamine
Class :
CNS stimulants
Dosage forms and strengthsÂ
oral capsule (extended-release)Â
10 mgÂ
12.5 mgÂ
15 mgÂ
20 mgÂ
25 mgÂ
30 mgÂ
37.5 mgÂ
5 mgÂ
50 mgÂ
oral tablet Â
10 mgÂ
12.5 mgÂ
15 mgÂ
20 mgÂ
30 mgÂ
5 mgÂ
7.5 mgÂ
Attention-deficit/hyperactivity Disorder (ADHD)Â
(immediate-release)
starting dose is 5 mg, taken orally once or twice a day
dose may be escalated by 5 mg per week if necessary
40 mg per day is the maximum dose limit higher doses are rarely necessary
(extended-release)
“Starting treatment for the first time or transitioning from another medication”
20 mg orally everyday
(immediate-release)
initial oral dose is 10 mg per day, which is usually divided into multiple doses throughout the day
dose may be raised by 10 mg per week
Dosage forms and strengthsÂ
Attention Deficit DisorderÂ
(immediate-release)
Age 3-5 Years:Â
starting dose is 2.5 mg per day, taken orallyÂ
daily dose may be increased by 2.5 mg each week
Age 6-17 Years:
starting dose is 5 mg, to be taken orally once or twice per dayÂ
dose may be increased by 5 mg every week Â
maximum dose is typically 40 mg per day, and only in rare circumstances would a higher dose be necessaryÂ
(extended-release)
Age 6-12 Years:Â
“Starting treatment for the first time or transitioning from another medication”Â
starting dose is to take either 5 or 10 mg orally once per day in the morningÂ
dose may be increased by 5 to 10 mg each week as neededÂ
The maximum daily dose is 30 mgÂ
Age 13-17 Years:Â Â
“Starting treatment for the first time or transitioning from another medication”Â
Starting dose is 10 mg, taken orally once per dayÂ
dose of the medication may be raised to 20 mg if the symptoms deteriorateÂ
The maximum daily dose is 30 mgÂ
Attention-deficit/hyperactivity Disorder (ADHD)Â
(immediate-release)
Age 3-5 Years:
starting dose is 2.5 mg per day, taken orally
daily dose may be increased by 2.5 mg each week
Age 6-17 Years:
starting dose is 5 mg, to be taken orally once or twice per day
dose may be increased by 5 mg every week
maximum dose is typically 40 mg per day, and only in rare circumstances would a higher dose be necessary
(extended-release)
Age 6-12 Years:
“Starting treatment for the first time or transitioning from another medication”
starting dose is to take either 5 or 10 mg orally once per day in the morning
dose may be increased by 5 to 10 mg each week as needed
The maximum daily dose is 30 mg
Age 13-17 Years:
“Starting treatment for the first time or transitioning from another medication”
Starting dose is 10 mg, taken orally once per day
dose of the medication may be raised to 20 mg if the symptoms deteriorate
The maximum daily dose is 30 mg
(immediate-release)
Age: 6-11 Years:
Starting dose is 5 mg per day, taken orally and divided into multiple doses throughout the day
dose may be increased by 5 mg every week until the desired therapeutic response is achieved
Age: >12 Years:
initial oral dose of this medication is 10 mg per day, divided into several doses throughout the day
dose may be gradually increased by 10 mg per week until the desired therapeutic effect is attained
Actions and Spectrum:Â Â
Action:Â
amphetamine and dextroamphetamine act on the neurotransmitters dopamine, norepinephrine, and serotonin in the brain. This drug induces the release of these neurotransmitters into the synapse, which results in their increased availability to bind to receptors.This results in an increase in overall brain activity, leading to increased focus, attention, and alertness.Â
Spectrum:Â Â
amphetamine and dextroamphetamine are primarily used in the treatment of ADHD and narcolepsy. In ADHD, they help to reduce symptoms such as inattention, hyperactivity, and impulsivity. In narcolepsy, they help to reduce excessive daytime sleepiness and improve alertness.Â
Frequency defined Â
>10% (Extended Release)Â
Abdominal pain (11-14%)Â
Insomnia (12-27%)Â
Loss of appetite (22-36%)Â
Weight loss (4-11%)Â
Abdominal pain (11-14%)Â
Headache (<26%)Â Â
1-10% (Extended Release)Â
Anxiety (8%)Â
Tachycardia (6%)Â
Nausea (5-8%)Â
Emotional lability (2-9%)Â
Infection (4%)Â
Diarrhea (2-6%)Â
Fever (5%)Â
Vomiting (7%)Â
Dizziness (2-7%)Â
Nervousness (6%)Â
Black Box Warning:Â Â
The black box warning for amphetamine/dextroamphetamine (Adderall) is related to the risk of abuse and dependence. Â
The stimulant medication is commonly used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. The black box warning highlights the potential for abuse, which can lead to dependence, addiction, and serious cardiovascular events.Â
The black box warning specifically states that amphetamine/dextroamphetamine should be prescribed cautiously and for short-term use only in patients with a history of substance abuse or dependence.
Contraindication/Caution:Â Â
Hypersensitivity: Individuals with a known hypersensitivity or allergy to amphetamine or dextroamphetamine, or any other ingredients in the medication should not take it. Â
Cardiovascular disease: Patients who have advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, or other significant cardiac issues are not recommended to use this drug Â
Glaucoma: The drug should not be used in patients with known or suspected glaucoma or a history of closed-angle glaucoma. Â
Hyperthyroidism: This medication is contraindicated in patients with hyperthyroidism, as it may exacerbate the condition. Â
Substance abuse: Individuals who have a history of alcohol or drug abuse may be more susceptible to abuse or addiction to this medication and should refrain from using it.Â
Agitation: This drug may exacerbate symptoms of agitation, anxiety, or psychosis, and should be avoided in patients with these conditions. Â
MAO inhibitors: This drug is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or who have taken them within the last 14 days, as this can lead to dangerous interactions and potentially life-threatening side effects.Â
Pregnancy warnings:    Â
Pregnancy category: N/AÂ
Lactation: Excreted into human milk is unknownÂ
Pregnancy Categories:        Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.Â
Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Pharmacology:
The drug combines two stimulant drugs that act on the central nervous system. The drug is primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.Â
Pharmacodynamics:Â
The drug’s pharmacodynamics is related to its impact on the central nervous system, where it acts as a powerful stimulant. Â
MOA:  The mechanism of action of this drug is thought to involve inhibition of the reuptake of dopamine, norepinephrine, and serotonin, thereby increasing their levels in the brain and promoting their release from the synaptic clefts. Â
Pharmacokinetics:Â
AbsorptionÂ
The drug is readily absorbed from the gastrointestinal tract and reaches its maximum plasma concentration about three hours after oral administration.Â
DistributionÂ
The drug exhibits extensive distribution throughout the body and has the ability to penetrate the blood-brain barrier. It is highly lipophilic and can accumulate in adipose tissue, leading to a long half-life.Â
MetabolismÂ
Metabolism of the drug occurs primarily in the liver through deamination and oxidation process. The major metabolites are 4-hydroxyamphetamine and norephedrine. Â
Elimination and excretion The drug and its metabolites are excreted primarily in the urine, with about 30-40% of the drug excreted unchanged.
Administration:  Â
Dosage: The appropriate dosage for this medication may differ based on factors such as the patient’s age, weight, and medical condition. It is crucial to adhere to the prescribed dosage guidelines given by a healthcare practitioner. Â
Timing: The drug is usually taken once or twice a day, depending on the patient’s needs. It is typically taken in the morning or early afternoon to avoid interfering with sleep.Â
Patient information leafletÂ
Generic Name: amphetamine/dextroamphetamineÂ
Why do we use amphetamine/dextroamphetamine? Â
These medications increase neurotransmitters in the brain, such as dopamine and norepinephrine. This can improve attention, concentration, and alertness, and help individuals with ADHD to better control their impulses and manage their symptoms.
Additionally, the drug can help individuals with narcolepsy stay awake during the day and improve their overall functioning. It is crucial to note that these drugs may cause adverse effects and should be taken under the guidance of a healthcare professional.Â
Â